110 related articles for article (PubMed ID: 8612110)
1. Immunotherapy for childhood asthma: is there a rationale for its use?
Sigman K; Mazer B
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):299-305; quiz 305-9. PubMed ID: 8612110
[TBL] [Abstract][Full Text] [Related]
2. [Allergen-specific immune therapy in the treatment of asthma].
Malling HJ
Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
[TBL] [Abstract][Full Text] [Related]
3. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
4. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
5. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
6. New visions in specific immunotherapy in children: an iPAC summary and future trends.
Halken S; Lau S; Valovirta E
Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
[TBL] [Abstract][Full Text] [Related]
7. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
10. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
11. Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children.
Bahir A; Goldberg A; Mekori YA; Confino-Cohen R; Morag H; Rosen Y; Monakir D; Rigler S; Cohen AH; Horev Z; Noviski N; Mandelberg A
Ann Allergy Asthma Immunol; 1997 May; 78(5):506-12. PubMed ID: 9164365
[TBL] [Abstract][Full Text] [Related]
12. [Specific immunotherapy in allergic asthma].
Bergmann KC
Pneumologie; 2003 Feb; 57(2):84-90. PubMed ID: 12579463
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
[TBL] [Abstract][Full Text] [Related]
15. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
17. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
Nagata M; Tanaka K
Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
19. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
[TBL] [Abstract][Full Text] [Related]
20. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
